Form 4: Biote Corp. Director Andrew R. Heyer Reports Acquisition of Stock Options and Restricted Stock Units

Director Andrew R. Heyer reports acquisition of stock options and restricted stock units in Biote Corp.

Summary

• On May 21, 2024, Andrew R. Heyer, a director of Biote Corp., reported the acquisition of 65,258 stock options with an exercise price of $5.57, expiring on May 20, 2034.
• Heyer also acquired 13,427 Deferred Settlement Restricted Stock Units (RSUs), each equivalent to one share of Class A Common Stock.
• The RSUs are fully vested upon grant but will be settled upon Heyer's separation from service.
• The stock options will vest on the earlier of May 21, 2025, or the day before the Issuer's 2025 Annual Meeting of Stockholders, contingent upon continuous service.
• Following these transactions, Heyer directly owns 175,459 stock options and 25,436 Deferred Settlement RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of stock options and RSUs by a director suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of stock options and RSUs by a director signals confidence in the company's future performance.
• The vesting schedule for the stock options incentivizes continued service and commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the stock options suggests an expectation of continued service and commitment from the director.

Industry Context

This filing is a routine disclosure of insider transactions, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders, which can be informative for investors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The vesting schedule for the stock options incentivizes the director to remain committed to the company's success.

Key Dates